Close

Oppenheimer Reiterates an 'Outperform' on Questcor Pharmaceuticals (QCOR); Expansion Strategy Into Rheumatology

June 15, 2012 8:56 AM EDT Send to a Friend
Oppenheimer reiterates an 'Outperform' on Questcor Pharmaceuticals (NASDAQ: QCOR) price target raised to $59.00.

Analyst, Christopher Holterhoff, said, "On ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login